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Bioreporter bacteria, i.e., strains engineered to respond to chemical exposure by production of reporter
proteins, have attracted wide interest because of their potential to offer cheap and simple alternative
analytics for specified compounds or conditions. Bioreporter construction has mostly exploited the natural
variation of sensory proteins, but it has been proposed that computational design of new substrate binding
properties could lead to completely novel detection specificities at very low affinities. Here we reconstruct a
bioreporter system based on the native Escherichia coli ribose binding protein RbsB and one of its
computationally designed variants, reported to be capable of binding 2,4,6-trinitrotoluene (TNT). Our
results show in vivo reporter induction at 50 nM ribose, and a 125 nM affinity constant for in vitro ribose
binding to RbsB. In contrast, the purified published TNT-binding variant did not bind TNT nor did TNT
cause induction of the E. coli reporter system.
C
onstruction of bioreporter bacteria typically starts with identifying a sensory protein that controls express-
ion of a target gene promoter in dependence on one ormore chemical inducers1–8. As an example, theArsR
protein represses its cognate promoter Pars, but when cells are exposed to arsenite (AsIII), this oxyanion
will interact with ArsR causing it to lose affinity for the operator site close to Pars, thus increasing the rate of
transcription from Pars6. The expression of reporter genes, such as those for luciferase, autofluorescent proteins or
beta-galactosidase, when coupled to Pars, will consequently increase in the presence of arsenite; it is this increase in
reporter protein signal or activity that is quantified in the bioreporter assay9. Despite the interest in and potential
applicability of bioreporter assays, the weak part in their design is the availability of suitable sensory proteins for
recognition of the target chemicals. Most of the ‘‘low-hanging fruits’’ in form of bacterial transcription regulators
for e.g., heavy metals and metalloids, organic compounds or global stress responses, have been exploited7,10–14.
Although it has been shown to be possible to somewhat expand substrate recognition properties of known
transcription regulators through mutagenesis and selection, this is a rather cumbersome approach15–20. In this
context, a landmark study over ten years ago suggested a completely different framework for the construction of
bioreporter systems, based on computerized design of de novo substrate binding properties of periplasmic
binding proteins (PBPs)8. Substrate binding to the redesigned PBP would lead to an interaction with a hybrid
membrane receptor, thereby triggering reporter gene expression, as will be explainedmore in detail below (Fig. 1).
PBPs consist of a broad class of proteins that carry a conserved protein structure, the bilobal structural fold21.
PBPs scavenge molecules for the cell, which they can present to specific transporter channels, and/or link
compound binding to chemotactic movement. As an example, the galactose- (GBP) and ribose-binding proteins
(RBP) of Escherichia coli enable the cell to sense galactose and ribose, respectively22. The sugars are bound by their
respective PBP, and a fraction of sugar-bound GBP and RBP binds to the Trg chemoreceptor; the other fraction is
presented to the transport channels MglAC (for GBP-galactose) or RbsAC (for RBP-ribose)23.
The binding of the PBP to a chemoreceptor can be transformed into de novo gene expression by using a hybrid
membrane chemoreceptor-histidine kinase. This was shown almost 20 years ago by the group ofHazelbauer, who
linked the EnvZ histidine kinase of the E. coli osmoregulation system to the Trg receptor via the so-called HAMP
domain (Fig. 1a)24. TheHAMPdomain is a conserved domain among histidine kinases, adenylyl cyclases,methyl-
accepting chemotaxis proteins and phosphatases, and plays a crucial role in signal transduction25. The resulting
hybrid receptor kinase (named TrzI) combines the 265 N-terminal amino acids of Trg with the 230 C-terminal
amino acids of EnvZ24. Galactose-GBP and/or ribose-RBP binding to TrzI will trigger histidine kinase activity of
the cytoplasmic EnvZ-domain, leading to phosphorylation of the cognate DNA-binding response regulator
OmpR. Phosphorylated OmpR (OmpR , P) binds the low affinity sites within the OmpC promoter (PompC)
and increases transcription rate from this promoter (Fig. 1a)26. A proof of concept was presented by fusing PompC
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with the gene coding for b-galactosidase (lacZ) in E. coli, demonstrat-
ing that trzI expression yielded enhanced b-galactosidase activity
when exposed to increasing ribose concentrations24.
Amajor conceptual advancement wasmade when it was proposed
that by molecular dynamics modeling, on the basis of the resolved
crystal structure of RBP,with andwithout ligand, it would be possible
to predict the amino acid changes in RBP necessary for binding with
new ligands27. This would create a possibly universal scaffold for
engineering of new ligand-binding specificities, which could all be
hosted in the same signaling ‘‘chassis’’ presented by the hybrid TrzI-
OmpR system. To provide proof of principle, the binding pockets of
glucose-binding protein (GBP), ribose-binding protein (RBP), ara-
binose-binding protein (ABP), glutamine-binding protein (QBP)
and histidine-binding protein (HBP) were redesigned by computa-
tional simulation in order to bind toxic and non-natural molecules,
such as serotonin, dinitrotoluene and TNT8. Simulation results sug-
gested that nM binding affinities could be obtained, and experi-
mental data were presented showing that expressing the mutant
RBPs in an E. coli TrzI-OmpR background with ompCp-lacZ
reporter led to nM detection specificity of TNT by measuring b-
galactosidase activity8.
Motivated by the potential importance and implications of a uni-
versal scaffold for the engineering of bioreporter ligand specificity,
we have set out to repeat the construction of one of the developed
bioreporter strains with reported nM affinity for recognition of
TNT8. A wide variety of methods is available for detection of TNT
Figure 1 | Schematic outline of the ribose-binding protein based reporter signaling chain. (a) Ribose-binding protein (RBP) captures its ligand, leading
to a conformational change. Ribose-RBP binds the TrzI hybrid transmembrane receptor, which causes a phosphorylation cascade leading to OmpR, P
binding the ompC-promoter and consecutive gfpmut2 expression. (b) Relevant plasmid constructions. rbsB or tnt.R3 with original rbsB periplasmic
export signal sequence and 39-hexahistidine tag under transcriptional control of the weak constitutive PAA promoter
29. Plasmid pSYK1 with gfpmut2
under the ompC promoter control and trzI under control of Ptac (note that pSYK1 carries the lacI
q gene).
www.nature.com/scientificreports
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(see, for example, ref. 28), but bioreporter-based assays could be
interesting for field application. Genes for both wild-type (rbsB)
and mutant RBP (tnt.R3) were produced by DNA synthesis and
cloned in an E. coli TrzI-OmpR background expressing the
GFPmut2 protein from the ompC-promoter, to measure sensitivity
of the reporter strains for ribose and TNT, respectively. We exam-
ined expression of wild-type and mutant proteins in the reporter
strains, and have investigated ligand binding of the purified proteins
by iso-thermal calorimetry (ITC). Whereas wild-type RBP produced
an excellent and sensitive ribose sensor in E. coli, the published TNT-
binding RBP variant did not show any significant binding to TNT,
and the bioreporter cells harbouring it did not display any response
to TNT or ribose.
Results
In vitro characterization of RbsB and TNT.R3 substrate binding.
To test substrate binding by RbsB and TNT.R3 we purified both
proteins from E. coli and determined the heat released by substrate
addition to the purified protein fractions by isothermal micro-
calorimetry (ITC). Both proteins were overexpressed from the T7
promoter as C-terminal hexahistidine tagged variants in E. coli BL21
(DE3) pLysS using IPTG induction of the T7 RNA polymerase.
Proteins were purified from culture-cleared lysates using Ni-NTA
affinity chromatography. Figure 2 shows the different affinity
binding steps and the purity of the final protein fraction (Elution
II, at 250 mM imidazol). Concentrations of RbsB-His6 and TNT.R3-
His6 after elution were between 0.2 and 0.8 mg/mL (Table 1).
Addition of 250 mM ribose to 34 mM RbsB-His6 solution pro-
duced clear evidence for ribose binding with successively decreased
heat release upon accumulated ribose additions (Fig. 3a). Assuming a
single binding site for ribose per RbsB, an affinity constant (Kd) of
125 nM was calculated from the fitted data sets. Titration of buffer
into RbsB-His6 solution, or of ribose solution into buffer produced
no heat release (Figure S1). In contrast, neither 1 mM TNT nor
1 mM ribose titration into 20 mM TNT.R3-His6 solution released
heat that was different from the addition of buffer alone
(Figure 3b, c). Titration of TNT alone into buffer did not produce
any consistent heat release as well (Figure S1).
Because the maximum aqueous solubility of TNT, 140 mg/L at
20uC,may have been limiting for saturation of TNT.R3 binding sites,
we also tested the opposite titration in ITC (i.e., protein into substrate
solution). In this manner, the TNT concentration in the measure-
ment cell can be maintained below aqueous solubility. However,
titration of 50 mM TNT.R3-His6 solution into 150 mM TNT also
did not produce consistent heat release (Figure S1A, B). In contrast,
titration of 100 mM RbsB-His6 solution into 4 mM ribose did pro-
duce heat release (Figure S1C), although in comparison to the bind-
ing curve in Figure 3a the injection peaks were not as clear. This may
have been due to secondary effects caused by the dissolution of
protein agglomerates during the injection. We thus concluded from
the in vitro experiments that purified RbsB-His6 is indeed capable of
binding ribose, but that TNT.R3-His6 neither binds TNT nor ribose,
although the protein can be purified and is detectable on SDS-PAGE
without any apparent degradation (Fig. 2b).
RBP-based bioreporter assays. To verify that E. coli expressing the
TrzI-hybrid-OmpR signaling chain is indeed a good chassis for an
RbsB-based bioreporter, we reconstructed a reporter strain using
gfpmut2 instead of the original lacZ under control of the ompC
promoter (Fig. 1b, plasmid pSYK1), and measured induction of
GFPmut2 over time in the presence of different sugars. This E. coli
(strain 4175) lacks the chromosomal rbsB but constitutively
expresses rbsB-his6 from a moderately constitutive promoter (PAA,
plasmid pAR3). In addition, this strain expresses trzI from the lac
promoter and carries the ompCp-gfpmut2 fusion (both on plasmid
pSYK1). Background fluorescence of E. coli BW25113 strain 4175
grown on MM with fumarate as sole carbon and energy source was
very low, and the lowest measured ribose concentration that resulted
in statistically significant GFPmut2 induction compared to the
medium-only control within 2 h incubation time was 50 nM
(Fig. 4a). Maximum induction reached 25-fold at a ribose con-
centration of 10 mM (Fig. 4c). To determine the reporter strain’s
specificity we examined GFPmut2 production upon addition of a
variety of other sugars, the majority of which (xylose, arabinose,
sucrose, fructose, maltose, mannose, lactose) did not elicit any
GFPmut2 induction from the E. coli reporter strain at
Figure 2 | Purification and expression in E. coli of RbsB-His6 and TNT-
His6. (a) Coomassie-stained SDS-PAGE gel of purified fractions of RbsB-
His6 from E. coli BL21 (pAR1, strain 3725). Lanes: 1, cleared lysate; 2,
flowthrough; 3, Washing step I; 4, Washing step II; 5, Peqgold protein
marker 2; 6, Elution I; 7, Elution II; 8, Elution III; 9, Elution IV. (b) As A,
but for E. coli BL21 (pAR2, strain 3325). Lanes: as for panel (A).
(c) InVision His6-tag stained SDS-PAGE gel of cell extracts from E. coli
BW25113DrbsB (pSYK1) expressing rbsB-his6 (from plasmid pAR3, strain
4175), tnt.R3-his6 (from plasmid pAR4, strain 4176), or with empty pSTV
plasmid (strain 4497). Left panel, periplasmic protein fraction. Right
panel, whole soluble protein fraction. Open triangle indicates the expected
position (30 kDa) of RbsB-His6 and TNT.R3-His6.
www.nature.com/scientificreports
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concentrations below 1 mM. In contrast, significant GFPmut2 pro-
duction was observed upon incubation with galactose and glucose
between 300 nM and 10 mM (Fig. 4d, e). This is likely caused by
interference from GBP, which can bind either galactose or glucose,
and interacts in its closed (substrate-bound) configuration with the
hybrid receptor TrzI (Fig. 4f). The reaction to glucose is lower than to
galactose at the same concentration, possibly due to the more rapid
metabolism of this sugar.
Next, we examined the possible influence of a number of key
proteins in the chemotaxis or osmolarity sensing pathways on
reporter gene induction in the trzI-ompR ompCp-gfpmut2 biorepor-
ter strain. Figure 4b displays the characteristic GFPmut2 induction
profiles of E. coli BW25113 carrying individual gene deletions as a
function of ribose concentration, whereas Figure 4c shows the fold
induction levels. In comparison to BW25113 lacking native rbsB, the
isogenic strain with envZ interruption showed a loss of responsive-
ness to ribose (Fig. 4b). In contrast, interruption of rbsK increased the
sensitivity of the reporter to ribose (Fig. 4b). A less drastic increase in
sensitivity was obtained when deleting trg or fliC. Deleting ompC or
ompF had very little effect on the sensitivity of the reporter strain for
ribose (Fig. 4b).
Interestingly, depending on the host, on ribose concentration and
on the deleted gene, the heterogeneity of GFPmut2 production
among cells in the population varied significantly (Fig. 5). In general,
the per-cell variability in GFPmut2 expression decreased at higher
inducer concentrations (Fig. 5). Compared to the host without func-
tional chromosomal rbsB, deletion of fliC, ompC, or rbsK led to a
more homogenously reacting population at lower ribose concentra-
tions (i.e., lower coefficient of variation, Fig. 5c, d, f). Conversely,
deleting ompF or envZ resulted in higher cellular variability of
GFPmut2 production, almost irrespective of ribose concentrations
(Fig. 5a, e). Deleting the chromosomal trg chemoreceptor did not
result in any difference of GFPmut2 heterogeneity compared to the
DrbsB strain (Fig. 5b, g).
A non-functional TNT bioreporter. In contrast to the wild-type
rbsB-based reporter, replacing rbsB by tnt.R3 in an isogenic host
background (E. coli BW25113 DrbsB, strain 4176, Table 2) led to
complete loss of sensitivity to ribose (Fig. 4a). More importantly,
the tnt.R3-based bioreporter was completely unresponsive to TNT
over a broad concentration range, 0.06 to 4 mM (Fig. 4a). Since we
did not observe any reporter signal from the reconstructed TNT.R3
bioreporter, but excellent sensitivity from the wild-type RbsB
bioreporter for ribose, we also examined whether E. coli BW25113
expressed the TNT.R3 protein from the PAA-promoter and
periplasmic transport signal sequence at the same level as the RbsB
protein (Fig. 1b). Expression of the RbsB-His6 and TNT.R3-His6
proteins in the BW25113 bioreporter strain is under control of the
same low constitutive PAA-promoter29 in the same plasmid
background. Unfortunately, anti-His6-antibodies did not produce
sufficient sensitivity and selectivity to detect both proteins in
Western blots of cytoplasmic cell extracts from the BW25113
strains (not shown). In-gel staining of the His6-tag revealed
fluorescent bands with an apparent size of around 30 kDa in the
cytoplasmic protein fraction, which were not completely specific
for the expressed RbsB-His6 and TNT.R3-His6 in extracts from E.
coliBW25113 (Fig. 2c). Analysis of the periplasmic fraction indicated
presence of a detectable RbsB-His6 but not TNT.R3-His6 (Fig. 2c).
Gel-extracted and trypsin-digested protein fractions in the size range
of 28–36 kDa were further analyzed by nano-liquid chromatography
followed by direct peptidemass identification (Table 3). This analysis
confirmed that both RbsB-His6 and TNT.R3-His6 are produced by E.
coli BW25113 DrbsB from the PAA-promoter. However, whereas we
identified RbsB-His6 in the whole soluble and in the periplasmic
Table 1 | Protein concentrations during purification of RbsB-His6
and TNT.R3-His6 from E. coli BL21 (DE3)
Sample
Total protein concentration (mg/ml)
RbsB-His6 TNT.R3-His6
Column flow through 43.9 27.1
Washing step I 22.9 14.4
Washing step II 2.4 1.2
Elution I 5.0 0.7
Elution II 0.8 0.2
Elution III 0.12 0.01
Figure 3 | In vitro substrate binding using isothermal microcalorimetry. (a) Injections of 250 nM ribose into 34 mM purified RbsB-His6 solution.
(b) Injections of 1 mMTNT into 50 mMpurified TNT.R3-His6 solution. (c) Injections of 1 mMribose into 50 mMpurified TNT.R3-His6 solution. Graphs
display immediate heat release in mcal/s (upper panels) and calculated heat release permol of injectant (lower panels). Note the expected binding of ribose
to RbsB (A), but the absence of any detectable binding of TNT or ribose by TNT.R3. For further controls see SI Figure 1.
www.nature.com/scientificreports
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protein extracts, TNT.R3-His6 was only detectable in the whole
soluble but not in the periplasmic protein extract (Table 3). We
conclude from this part that whereas both RbsB-His6 and
TNT.R3-His6 are produced from the same plasmid type and
promoter in E. coli, TNT.R3-His6 is less abundant and does not
seem to be transported into the periplasmic space.
Discussion
We revisit here the use of a PBP-basedmicrobial biosensor, proposed
over a decade ago as a general scaffold for computational design of
new binding specificities8,30. We show through independent de novo
synthesis that a wild-type RbsB-based signaling cascade is fully func-
tional in detecting low concentrations of ribose, but one of the most
interesting computationally designed variants for detecting TNT8 is
not. We conclude this from three different experimental lines of
evidence. First, we demonstrated that the purified RbsB bound
ribose, as expected, whereas purified TNT.R3 protein bound neither
TNT nor ribose at detectable levels (Fig. 3). Second, constitutive
expression of rbsB-his6 under a moderate promoter in an E. coli
harboring the TrzI hybrid receptor and ompCp-gfpmut2 fusion led
to a ribose-dependent production of GFPmut2 fluorescence already
at 50 nM ribose (Fig. 4a, c). In contrast, assays in the same genetic
background and plasmid constructions with a tnt.R3-his6 gene pro-
duced no detectable GFPmut2 in presence of either TNT or ribose
(Fig. 4a). Finally, we showed that both RbsB-His6 and TNT.R3-His6
are produced in such E. coli background, but whereas RbsB-His6
appears to reach the periplasmic space we did not find evidence that
this is also true for TNT.R3-His6 (Fig. 2c, Table 3). The absence of
any reporter signal in strains carrying the tnt.r3-his6 gene to TNT is,
therefore, unlikely the result of poor expression of TNT.R3-His6.
Possibly, the introduced mutations in the TNT.R3 variant that were
predicted to turn RbsB into a TNT-binder, made the protein less
stable in the cytoplasmic environment (Table 3), and hindered the
folding and transport process. In addition, it is possible that the
intramolecular movement upon ligand binding, or even the binding
to the TrzI receptor, are affected. But since we have no evidence that
TNT.R3-His6 reaches the periplasmic space (Table 3), this is a less
likely explanation for the absence of GFPmut2 fluorescence in
tnt.R3-his6 reporter strains. Misfolding of the protein was not spe-
cifically examined in our assays, but had been suggested as a reason
for concern in other studies performed in order to structurally char-
acterize the computational designs of the receptors31–33.
We acknowledge that the original study designed a number of
periplasmic-binding-protein variants, of which we independently
reconstructed only the one proposed as the most prominent8. We
find that the published TNT.R3mutant cannot be used as a sensor for
the detection of TNT, contrary to the reported lowest detection limit
of between 1024 and 1023 mM and a Kd of 2 nM8, a value 65 times
lower than the affinity we measured for the wild type RbsB protein
towards ribose (125 nM). These findings, however, do not null the
notion that a platform using biosensors based on periplasmic bind-
ing proteins could be a powerful tool. Indeed, E. coli expressing RbsB
in combination with the TrzI-hybrid-OmpR ompCp-gfpmut2 signal-
ing chain turned out to be an excellent reporter for ribose (method
detection limit of ,50 nM), with a good selectivity (no reaction to
multiple sugars and 10-fold lower detection threshold of ribose than
galactose, Fig. 4). We showed that the response from the hybrid
signaling chain could even be further optimized by using an rbsK-
mutant of E. coli rather than rbsB (Fig. 4C, D). The higher response of
this strain to ribose may be explained by the fact that deleting rbsK
Figure 4 | Reporter gene expression from the hybrid TrzI-OmpR-ompCp::gfpmut2 signaling chain. (a) Average GFPmut2 fluorescence in flow
cytometry (detected using the FITC channel, arbitrary units), as a function of ribose or TNT concentration after 2 h induction time, for E. coli BW25113
DrbsB expressing rbsB-his6 (strain 4175) or tnt.r3-his6 (strain 4176). (b) As A, but as a function of ribose exposure only and for a range of E. coli BW25113
backgrounds (Table 2). (c) As B, but expressed as -fold induction compared to the blank. (d) As A, but as a function of exposure to different sugars for E.
coli BW25113 DrbsB expressing rbsB-his6 (strain 4175). (e) As D, but expressed as -fold induction compared to the blank. (f) Average GFPmut2
fluorescence of E. coli BW25113 DrbsB (pSYK1, pSTV28, strain 4497) exposed to glucose, galactose or ribose. Data points show means of GFPmut2
fluorescence from biological triplicate assays, each sampling 10,000 cells. Error bars indicate calculated standard deviations from the mean (when not
visible, inside symbol size).
www.nature.com/scientificreports
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interrupts ribose metabolism, leaving on average more ribose to
activate the signaling chain through RbsB-TrzI-OmpR rather than
going through the ribose transport system. Also, a trg host mutant
background produced a more sensitive response, but with overall
lower fold-induction (Fig. 4c), which may be due to less internal
competition for ribose-bound RbsB by the natural Trg chemotaxis
receptor. Deletion of envZ, ompF, and, surprisingly, fliC, resulted in a
much poorer response to ribose (Fig. 4b, c). Disruption of native
envZ may result, in spite of the presence of TrzI, in a lower overall
amount of OmpR, P in the cell, causing less frequent binding to the
weak-affinity OmpR-sites in the PompC promoter, and thus to a lower
level of gfpmut2 transcription. These results show that the host chas-
sis for a ribose-binding protein based reporter may be further
improved and would prove useful, once the limitations in computa-
tional design are overcome.
Along with techniques such as directed evolution, computational
protein design has been successful in the design of enzyme catalysts,
new protein folds, or antigens, but its predictions still fall short
especially in the protein-small molecule domain34–36. Many methods
adopted in the current context, including the technique of dead-end
elimination along with a semi-empirical potential energy function,
used in designing TNT.R3 and other PBP-variant receptors8, do not
take into consideration the flexibility of the protein backbone. This
concerns specifically the substrate binding pocket flexibility,
dynamics of the structure upon binding, and calculation of the pro-
tein stability or consistency of the 3D fold of the designs. Because of
the magnitude of the combinatorial search problem to be tackled in
protein design, the chemical accuracy of the calculations is signifi-
cantly reduced. For a receptor like RBP, the energetic or entropic cost
of the conformational re-organization or domain re-orientation dur-
ing binding can be very important but difficult to calculate. This also
holds for other relevant steps in the PBP signalling cascade, such as
the binding of the ligand-bound PBPwith the transmembrane recep-
tor. So far, therefore, these steps have not been included in energy
calculations.
Very recently, it has been demonstrated that in-silico design of
small-molecule binding proteins can drive the binding affinity down
to picomolar level37. The computationalmethodwasmodified so that
the designs have binding pockets similar to the naturally occurring
ones, in terms of the favourable hydrogen-bonding or van derWaals
interactions with the ligand, and high shape complementarity to the
ligand. These advances may be highly beneficial for the design of
sensory proteins and extremely advantageous to the biosensing field,
given that the set of known characterized transcription factors is
small and in view of the difficulties involved in the identification of
suitable transcription factors for the detection of new compounds of
interest.
Methods
Strains and growth conditions. All E. coli strains used for this work are listed in
Table 2. For cloning purposes, E. coli strains were cultured at 37uC on Luria Bertani
(LB) medium38, supplemented with appropriate antibiotics to select for plasmid
maintenance. In case of ampicillin (Amp), a concentration of 100 mg/ml was used; for
chloramphenicol (Cm), we used 30 mg/ml. Culturing conditions for protein
overexpression and for reporter assays are specified below.
Plasmid constructions. The mutant tnt.R3 gene was produced by DNA synthesis
(DNA2.0, CA, USA) on the basis of the mutant sequence provided in Looger et al8.
The gene sequence further encoded a C-terminal hexahistidine (His6) tag, restriction
sites for NdeI (N-terminal), XhoI and BamHI (C-terminal), and for NcoI at the end of
the signal sequence (Figure S2). The wild type rbsB gene was amplified from pAI12 (a
kind gift of Hazelbauer’s lab, Pullman, Washington) using primers with restriction
sites forNdeI andXhoI. The PCR product was digested and placed into pET22b(1) in
order to attach the vector-located hexahistidine tag to the C-terminus of the rbsB
gene. The resulting rbsB-His6 gene was again amplified with primers containing NdeI
and SalI restriction sites. The PAA promoter29 used to drive constitutive transcription
of both tnt.R3 and rbsB was synthesized (DNA2.0) under inclusion of BamHI and
SacI restriction sites. The promoter fragment was first cloned into pUC18 and
recovered by SacI andXbaI digestion. This PAA-fragment was ligated with a recovered
DNA fragment containing the multiple cloning site of pET22(1) (using XbaI and
Figure 5 | Coefficient of variation of per-cell GFPmut2 expression as a
function of ribose concentration for different E. coli BW25113
backgrounds (A–G, Table 2) expressing rbsB-his6 from pAR3 and the
TrzI-OmpR-ompCp::gfpmut2 hybrid signaling chain of pSYK1. Bars
indicate the mean coefficient of variation from biological triplicate assays
(each measuring GFPmut2 expression in 10,000 cells), plus one calculated
standard deviation (error bar).
www.nature.com/scientificreports
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SalI), and with pSTV28 (Takara, Japan), digested with SacI and SalI. After
transformation in E. coli, this resulted in plasmid pSTV28PAAmcs. Finally, rbsB-His6
and tnt.R3-His6 were placed into pSTV28PAAmcs using NdeI and SalI or NdeI and
XhoI, respectively, resulting in pAR3 and pAR4 (Fig. 1b, Table 2).
For overexpression the synthesized tnt.R3-His6 fragment was digested with NcoI
and BamHI and placed into pET3d39 resulting in pAR2. This removes the signal
sequence for transport in the periplasmic space. RbsB-His6was amplified from pAI12,
now without the signal sequence using primers containing NdeI and XhoI restriction
sites. TheNdeI-XhoI fragment was purified and placed into pET22b(1) digestedwith
the same enzymes, directly in front of the hexahistidine tag. After transformation this
resulted in plasmid pAR1. All final constructs were verified by sequencing. Plasmids
for overexpression were transformed into E. coli BL21 (DE3) carrying pLysS40.
Plasmid pSYK1 carries the gene for the hybrid receptor trzI under the control of
Ptac and gfpmut2 under the control of PompC (Fig. 1b). The ompC promoter fused to
the gfpmut2 reporter gene was amplified from plasmid pUA66-ompC::GFPmut241
(kindly provided by Prof. Uri Alon from the Department ofMolecular Cell Biology at
the Weizmann Institute of Science, Rehovot, Israel) using primers that introduced
BamHI restriction sites on either end. This fragment was ligated into the unique
BamHI site of plasmid pRB020, which carries a lacIq gene and places trzI under
control of the tac promoter24. After transformation this resulted in plasmid pSYK1.
Reporter constructs were cotransformed into E. coli BW25113 background carrying
either rbsB deletion or deletions in other genes of the hybrid signaling pathway
(Table 2).
Analysis of expression of RbsB-His6 and TNT.R3-His6 in E. coli BW25113. Ten
mL LBmedium containing Amp and Cmwere inoculated with a single colony from a
freshly grown LB agar plate with both antibiotics, and incubated at 37uC. The cells
were harvested by centrifugation at 3200 x g at mid-exponential phase (OD6005 0.7)
and resuspended in 400 mL of 30 mM Tris-HCl containing 20% sucrose at a pH of
8.0. Half of the suspension (for the preparation of the total soluble protein fraction or
cell extract) was transferred to 1.5 mL screw-capped microtubes containing 0.1 g
acid-washed glass beads (,106 mm, Sigma, USA). Suspensions were homogenized in
a bead beater (Fastprep FP120, Thermo Electron, USA) for 30 s at a speed of 4.0.
EDTA was added to the other half to a final concentration of 1 mM for the
preparation of the soluble periplasmic protein fraction. This suspension was
incubated on ice for 10 min with gentle agitation. After centrifugation at 16,000 x g
for 20 min at 4uC the supernatant was removed and the pellet was resuspended in
200 mL of ice-cold solution of 5 mMMgSO4. During the following incubation on ice
for 10 min the tubes were inverted 10 times every minute for 10 s. Both whole soluble
and periplasmic fractions were centrifuged for 30 min at 16,000 x g and 4uC, after
which the supernatant was transferred to a clean Eppendorf tube and placed on ice.
Samples were then analyzed by SDS-polyacrylamide gel electrophoresis (PAGE), by
mixing various protein amounts with SDS loading buffer, according to Sambrook38.
Samples for SDS-PAGE were incubated for 5 min on a thermomixer (Eppendorf,
Schweiz) at 99uC, and centrifuged for 1 min at 16,000 x g immediately before loading.
The samples were loaded onto 13% acrylamide gel and proteins were separated for
1.5 h at 150 V, according to standard procedures38.
After electrophoresis the gels were stained using InVision colorant (Life tech-
nologies, USA) in order to detect His6-tagged proteins. The gel was placed into a
fixing solution (40% v/v ethanol and 10% v/v acetic acid in ultrapure water) for 1 h
and then washed with water for 20 min. Subsequently, the gel was washed with buffer
A (20 mM imidazole, 50 mMNaH2PO4 and 500 mMNaCl, pH 8.0) for 10 min, and
incubated with InVision stain for 1 h. The gel was destained with 20 mM phosphate
buffer (pH 7.8) for 20 min, and subsequently scanned on a Typhoon imager
(Amersham Biosciences, United Kingdom) at a resolution of 50 mm using a 532 nm
laser. Subsequently, gels were washed with water for 10 min, and restained using
Coomassie blue for 1 h according to standard procedures38. After destaining the gel
was photographed with a Nikon D5100 camera equipped with a 18–55 mm objective
(Nikon, Schweiz) under white light illumination.
Table 2 | List of strains used in this study with their relevant characteristics
Strain No Host Plasmid(s) Relevant characteristics Reference
97 E. coli BL21 (DE3) pLysS Host strain for overexpression from the T7 promoter 40
3325 E. coli BL21 (DE3) pLysS pAR2 Host 97, cytoplasmic overexpression of His6-tagged TNT.R3 This study
3725 E. coli BL21 (DE3) pLysS pAR1 Host 97, cytoplasmic overexpression of His6-tagged RbsB This study
4076 Escherichia coli BW25113 DrbsB rbsB 42
4175 E. coli BW25113 DrbsB pAR3 pSYK1 expression of His6-tagged RbsB with signal sequence from PAA
expression of TrzI, gfpmut2 fusion to ompC promoter
This study
4176 E. coli BW25113 DrbsB pAR4, pSYK1 as 4175, but expressing the TNT.R3 mutant protein This study
4497 E. coli BW25113 DrbsB pSTV28, pSYK1 as 4175, but with empty vector. This study
4500 E. coli BW25113 DompF ompF 42
4501 E. coli BW25113 Dtrg trg 42
4502 E. coli BW25113 DfliC fliC 42
4503 E. coli BW25113 DompC ompC 42
4504 E. coli BW25113 DenvZ envZ 42
4505 E. coli BW25113 DrbsK rbsK 42
4515 E. coli BW25113 DompF pAR3, pSYK1 as 4175 in host 4500 This study
4516 E. coli BW25113 Dtrg pAR3, pSYK1 as 4175 in host 4501 This study
4517 E. coli BW25113 DfliC pAR3, pSYK1 as 4175 in host 4502 This study
4518 E. coli BW25113 DompC pAR3, pSYK1 as 4175 in host 4503 This study
4519 E. coli BW25113 DenvZ pAR3, pSYK1 as 4175 in host 4504 This study
4520 E. coli BW25113 DrbsK pAR3, pSYK1 as 4175 in host 4505 This study
Table 3 | Occurrence of RbsB-His6 and TNT.R3-His6 in E. coli BW25113 DrbsB (pSYK1) protein fractions
Periplasmic protein fraction1 Whole soluble protein fraction1
Identified protein(s)
Strain 4175
RbsB-His6
Strain 4176
TNT.R3-His6
Strain 4497
Ctrl
Strain 4175
RbsB-His6
Strain 4176
TNT.R3-His6
Strain 4497
Ctrl
RbsB-His6 18 (8)2 5 (5) 4 (4) 14 (5) 1 (1) 1 (1)
TNT.R3-His6 ND3 ND ND ND 2 (2) ND
RbsB-His6 1 TNT.R3-His64 18 (5) 6 (6) ND 10 (5) 5 (3) ND
Total RbsB-His6 1 TNT.R3-His65 36 (13) 11 (11) 4 (4) 24 (10) 8 (6) 1 (1)
Total proteins 116 (387)6 86 (277)6 104 (349)6 259 (1273)6 234 (971)6 254 (1061)6
1) 28–36 kD fragments on SDS-PAGE gel from extracts as shown in Fig. 2C, originating from E. coli BW25113 DrbsB (pSYK1) expressing rbsB-his6 (from plasmid pAR3, strain 4175), E. coli BW25113
DrbsB (pSYK1) expressing tnt.R3-his6 (from plasmid pAR4, strain 4176), or E. coli BW25113 DrbsB (pSYK1) carrying empty pSTV (strain 4497, Ctrl).
2) Normalized number of peptide mass fragments identifying the protein(s) as total number of specific peptide fragments by the averaged total peptide count in the sample; between brackets, number of
unique peptide mass fragments identifying the protein(s).
3) ND, not detected.
4) Peptides covering regions common to both RbsB-His6 and TNT.R3-His6.
5) All peptides identifying both RbsB-His6 and TNT.R3-His6.
6) Total number of identified proteins within the 27–32 kDa purified gel region; within brackets: total number of identified peptide mass fragments.
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Expression and export of RbsB-His6 andTNT.R3-His6 from the PAA-promoter was
separately analyzed using direct peptidemass identification. E. coliBW25113 cultures
were grown and periplasmic or whole soluble protein fractions were prepared as
described above. Proteins were separated by SDS-PAGE and proteins in a size region
of 28-36 kD were excised. Proteins were subsequently digested with trypsin and
peptides were separated on an Ultimate 3000 Nano LC System (Dionex), followed by
detection in a Thermo Scientific LTQ-Orbitrap XL mass spectrometer (Thermo
Fisher Scientific, Waltham, MA). Mass spectra were analyzed using Scaffold Viewer
(http://www.proteomesoftware.com/), using protein and peptide identification
thresholds of 99.9% and 99.99%, respectively. The minimum number of peptides for
identification was 2.
RbsB-His6 and TNT.R3-His6 overexpression and purification. In order to analyze
in vitro substrate binding, we first overexpressed and purified RbsB-His6 and
TNT.R3-His6. We used the C-terminal added hexahistidine tag in combination with
Ni-NTA affinity column chromatography (Qiagen, Germany). Proteins were
overexpressed in E. coliBL21(DE3)pLysS carrying the appropriate plasmid (pAR1 for
RbsB-His6 or pAR2 for TNT.R3-His6). Cultures were launched at 37uC in 200 mL LB
medium containing 100 mg/mL Amp and 30 mg/mL Cm and inoculated with a single
colony from a freshly grown agar plate. At a culture turbidity of OD600 5 0.3
overexpression was induced through addition of IPTG to 1 mM final concentration.
Cultures were incubated further for 16 h at 20uC, after which the cells were harvested
by centrifugation at 3,200 x g in four 50 mL Falcon tubes. Cell pellets were stored at
280uC until protein isolation.
For purification of the His6-tagged proteins, one cell pellet was resuspended in
4 mL of buffer A (see above). The suspension was transferred into 1.5 mL screw-
capped plastic tubes containing 0.1 g glass beads (see above), and homogenized in a
bead beater (Fastprep) for 3 times at 20 s and a speed of 4.0, with intermittent cooling
on ice. After centrifugation for 30 min at 16,000 x g and 4uC the supernatant was
transferred to a clean tube, and mixed with 750 mL of Ni-NTA resin (Qiagen,
Germany) for one hour at 4uC using a multi axle rotator (A257, Denley Instruments
LTD, United Kingdom). Subsequently, the protein-Ni-NTA suspension was poured
onto a 1 mL polypropylene column (Qiagen, Germany) to collect the protein-bound-
resin. After consecutive washing with 1 mL of buffer A containing first 40 mM and
then 80 mM imidazole, the proteins were eluted in fractions of 600 mL using buffer A
containing 250 mM imidazole. Flow-through from the column was collected and
analysed by SDS-PAGE and Coomassie blue staining (see above). Protein concen-
trations were determined by using the Bradford assay and by NanoDrop spectro-
photometry (Thermo Scientific, USA), using the ‘‘Protein A280’’ mode with
calculated theoretical molar extinction coefficient and molecular weight as para-
meters. Purified protein was stored on ice and used within 5 h for the substrate-
binding assay, without further dialysis.
Analysis of substrate binding using isothermal microcalorimetry (ITC).
Quantified amounts of purified protein, typically 280 ml of between 0.6 and 1 mg/ml,
were pipetted into the measurement cell of an isothermal titration calorimetry
instrument (MicroCal iTC200, GE Healthcare Life Sciences, USA). A volume of
280 ml of elution buffer (buffer Awith 250 mM imidazole) was used as a reference. An
appropriate concentration of the test ligand (of between 0.25 and 1 mM in buffer A
containing 250 mM imidazole) was filled into the injection syringe. In other
experiments we tested injecting purified protein solution (of between 1.4 and 2.8 mg/
ml) into substrate solution in the measurement cell. The substrates tested were ribose
and TNT. Measurements were taken at 20uC, with a reference power of 11 mcal/s, a
stirring velocity of 1000 rpm and a ‘‘low feedback’’ mode. Raw data were recorded in
mcal/s over time and integrated to kcal/mol over molar ratio. Wherever possible
regression curves were calculated based on a one-binding site model.
RBP-based bioreporter assays using the TrzI-OmpR hybrid signaling chain. In
order to measure the capacity of RbsB or TNT.R3 to induce the TrzI-hybrid-OmpR
ompCp-gfpmut2 signaling chain in the presence of appropriate inducer, we used E.
coli BW25113DrbsB cotransformed with pSTV-based plasmids (pAR3, to express
rbsB, or pAR4 for tnt.R3) and plasmid pSYK1 (to provide the hybrid signaling chain,
see Table 2). Upon induction, these strains produce GFPmut2, the fluorescence
intensity of which was measured using flow cytometry. The bioreporter assay was
optimized for minimal background GFPmut2 expression and medium fluorescence.
Hereto, 5 mL of minimal medium with Amp and Cm (SI Table 1) with 20 mM
fumarate as sole carbon and energy source were inoculated with a single colony from a
freshly grown LB plate containing the same antibiotics. Cultures were incubated
overnight at 37uC with rotary shaking at 180 rpm. The next morning, 2 mL culture
aliquots were transferred into 5 mL of fresh minimal medium (SI Table 1), and
incubated for 4 h at 37uC with rotary shaking at 180 rpm. Samples (180 mL) of this
culture were then introduced into the wells of a 96-well plate (F96 Cert.Maxisorp,
Nunc, Denmark) and mixed with 20 mL of the appropriate ligand in a range of
concentrations to start induction. Notably, we used ribose (D-(-)-ribose, Aldrich,
USA) at concentrations between 7.8 nM and 250 mM. 2,4,6-Trinitrotoluene (TNT)
was purchased from Dr. Ehrenstorfer GmbH, Germany and used at concentrations
between 62 nM and 4 mM, by dissolving the TNT in water. Different other gene
deletion variants of BW2511342 were tested with the same plasmids, in order to
discern the effect of background host genes on the induction from the hybrid
signalling chain (Table 2). Induction was allowed to proceed for 2 h at 37uC, after
which aliquots of 150 ml of each of the wells were auto-sampled, and values of
individual cell forward scatter (FSC) and GFPmut2 fluorescence (FITC-channel)
were recorded by a Becton Dickinson Fortessa flow cytometer (LRS FortessaTM,
Becton Dickinson, USA). The flow rate was set to 3 ml/s and the cell density was
between 100-1000 cells/mL. Sensitivities for the FSC and the FITC channels were set
at 350 V and 676 V, respectively. Recorded data were gated to remove background
particles. The mean fluorescence values of the gated uninduced or induced
populations were calculated. All experiments were carried out in triplicate, and the
standard deviation and coefficient of variation were calculated from the mean
fluorescence.
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